This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Wide Market Index Fund Performance For Retirement matters for asset allocation. Learn how performance relates to drawdown tolerance and withdrawal needs.
28,258 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The TAN ETF has surged about 82% in the past year, but long-term holders face meaningful fee drag and concentration r...
The Nasdaq leads the charge as risk appetite returns, lifting major indices. This guide breaks down what’s driving th...
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...
The S&P 500 just completed straight week, marking a notable stretch of gains. This article breaks down what it could ...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
May surprised many investors with broad gains across major asset classes. This guide breaks down who led, why, and pr...
SpaceX led a historic IPO moment, but inflation is heating up alongside. This guide breaks down what that means for y...
A 69-year-old worker and a 67-year-old retiree face a pivotal retirement choice: keep funding a traditional IRA or pi...
Bitcoin whipped between gains and losses as geopolitical tensions intensified. A bold move by Strategy to add to BTC ...
The headline question is tempting: is the u.s. market broken? The reality is more nuanced. This guide breaks down wha...